[Histonet] Ventana Benchmark Ultra

[Bacon, Charles]

Hello Warda,

As you know the Dako Autostainer and PT link set up works well but has a good amount of tech time involved in its use. We currently run the Dako as well as the Benchmark Ultra. The Ultra is a major upgrade in ease of use. The antigen retrieval is onboard with no tech time to switch and load after that step, like on the Dako. Our pathologist do still like specific antibodies run on the Dako platform but that is getting very specific with antibodies. They all agree they work on the Ultra but "like it better on the Dako." To me it comes down to open or closed. With the Ventana we use mostly prediluted antibodies with some exceptions where we make a prep kit. On the Dako which we have had for years longer than the Ventana, there was more room for developing the specific nuance of a given antibody. We seem to be able to tweak the settings on the Dako more to our pathologist liking. In summation the Dako is a bit more open but to me you cannot weight that against tech time and TAT of the Benchmark. We run the PD-L1 developed by Dako so we will always need that platform, but I prefer the Ventana equipment overall.

Best,

Chuck Bacon, HTL(ASCP)CM 
Supervisor Histology
Baystate Medical Center
361 Whitney Ave., Holyoke, MA 01040
Telephone: 413-322-4786  Fax: 413-322-4790
Charles.Bacon at baystatehealth.org

-----Original Message-----
From: warda hassan <redrose297 at gmail.com> 
Sent: Wednesday, October 28, 2020 2:48 PM
To: histonet at lists.utsouthwestern.edu
Subject: [Histonet] Selection of IHC system

Dear Histonet

Our lab is looking to purchase a new IHC system.
Currently we are working with Dako.
I would request your valuable feedback on :-

1- Bond max ( Leica)
2- Bench Mark Ultra (Roche Diagnostic)

Workload is 15,000-20,000 slides/year.

Many thanks in advance for your help.

Kind regards
W.A Hassan



----------------------------------------------------------------------
Please view our annual report at http://www.bhannualreport.org
 

CONFIDENTIALITY NOTICE: This e-mail communication and any attachments may contain confidential and privileged information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please reply to the sender immediately or by telephone at 413-794-0000 and destroy all copies of this communication and any attachments. For further information regarding Baystate Health's privacy policy, please visit our Internet site at https://www.baystatehealth.org.